Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-17

Clinical Trial Update: A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 trial evaluating the safety and efficacy of abiraterone acetate in men with prostate cancer, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zytiga (abiraterone acetate)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-04-17